Header cover image

South Korean (KOSPI) Healthcare Sector Analysis

UpdatedFeb 24, 2024
DataAggregated Company Financials
Companies347
  • 7D1.7%
  • 3M10.4%
  • 1Y11.9%
  • YTD-5.3%

The Healthcare industry is up 1.0% in the last week, with ALTEOGEN up 45%. This takes the industry's 12 month performance to a gain of 9.3%. Looking forward, earnings are forecast to grow by 27% annually.

Sector Valuation and Performance

Has the South Korean Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 24 Feb 2024₩228.6t₩52.0t-₩48,458,490,006.0023x-4717.4x4.4x
Mon, 22 Jan 2024₩230.7t₩55.7t₩55.5b23x4159.2x4.1x
Wed, 20 Dec 2023₩216.7t₩56.1t₩280.7b21.5x772.2x3.9x
Fri, 17 Nov 2023₩208.8t₩56.0t₩1.0t19.1x204.5x3.7x
Sun, 15 Oct 2023₩204.8t₩56.0t₩1.0t18.7x200.1x3.7x
Tue, 12 Sep 2023₩220.2t₩56.0t₩930.7b20.7x236.5x3.9x
Thu, 10 Aug 2023₩222.0t₩56.1t₩2.1t23.1x106.2x4x
Sat, 08 Jul 2023₩199.1t₩56.1t₩2.1t20x94.6x3.5x
Mon, 05 Jun 2023₩219.1t₩56.3t₩2.1t21.1x103.9x3.9x
Wed, 03 May 2023₩210.8t₩58.4t₩3.2t20.4x64.9x3.6x
Fri, 31 Mar 2023₩201.6t₩58.2t₩3.4t19.7x58.5x3.5x
Sun, 26 Feb 2023₩201.1t₩57.8t₩4.6t19.4x43.7x3.5x
Tue, 24 Jan 2023₩203.8t₩57.8t₩4.6t17.4x44.2x3.5x
Thu, 22 Dec 2022₩210.3t₩57.5t₩3.9t16.4x54.2x3.7x
Sat, 19 Nov 2022₩215.1t₩56.7t₩4.0t15.9x54x3.8x
Mon, 17 Oct 2022₩192.2t₩55.7t₩4.1t14.9x47.2x3.4x
Wed, 14 Sep 2022₩211.0t₩56.0t₩4.2t17.5x49.8x3.8x
Fri, 12 Aug 2022₩237.0t₩54.2t₩3.9t20.7x61x4.4x
Sun, 10 Jul 2022₩219.5t₩54.2t₩3.9t18.7x56.5x4.1x
Tue, 07 Jun 2022₩227.5t₩54.2t₩3.9t22.4x58.3x4.2x
Thu, 05 May 2022₩226.2t₩51.1t₩3.9t22.7x58.3x4.4x
Sat, 02 Apr 2022₩232.3t₩50.9t₩4.1t21.6x56.7x4.6x
Mon, 28 Feb 2022₩218.3t₩49.0t₩4.3t21.1x50.6x4.5x
Wed, 26 Jan 2022₩221.5t₩49.0t₩4.3t20.6x51.3x4.5x
Fri, 24 Dec 2021₩261.3t₩49.0t₩4.3t24x60.5x5.3x
Sun, 21 Nov 2021₩262.6t₩48.3t₩4.4t22.1x59.1x5.4x
Tue, 19 Oct 2021₩266.1t₩48.0t₩4.3t22.6x62.4x5.5x
Thu, 16 Sep 2021₩302.3t₩49.5t₩4.3t30.6x70.2x6.1x
Sat, 14 Aug 2021₩314.6t₩49.5t₩4.3t30.3x73.5x6.4x
Wed, 09 Jun 2021₩276.3t₩44.3t₩2.9t27.4x95.6x6.2x
Tue, 02 Mar 2021₩255.2t₩42.7t₩2.2t26.6x115.9x6x
Price to Earnings Ratio

115.9x


Total Market Cap: ₩255.2tTotal Earnings: ₩2.2tTotal Revenue: ₩42.7tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Healthcare Sector Price to Earnings3Y Average 127.4x202220232024
Current Industry PE
  • Investors are relatively neutral on the South Korean Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 4.5x.
Past Earnings Growth
  • Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 6.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare sector?

KR Market0.76%
Healthcare1.72%
Healthtech6.16%
Medical Equipment4.02%
Biotech2.96%
Pharma2.12%
Healthcare Services-0.38%
Life Sciences-1.15%
Industry PE
  • Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 148x.
    • Analysts are expecting annual earnings growth of 14.3%, which is higher than its past year's earnings decline of 26.8% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 89% over the next 5 years.
  • This is better than its past earnings growth rate of 18% per year.
  • In contrast, the Life Sciences industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A196170 ALTEOGEN₩131.20k44.7%
+₩2.1t
243.9%PE1077.1x
A028300 HLB₩78.70k14.7%
+₩1.3t
146.3%PS154.8x
A326030 SK Biopharmaceuticals₩92.60k8.4%
+₩563.9b
41.4%PS24.9x
A000100 Yuhan₩67.00k7.0%
+₩328.8b
31.5%PE57.8x
A328130 Lunit₩67.40k9.2%
+₩163.9b
199.9%PS82x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A068270

₩180,000.00

Celltrion

7D

-1.2%

1Y

20.6%

A302440

₩63,900.00

SK bioscienceLtd

7D

-1.4%

1Y

-9.9%

A039200

₩22,850.00

Oscotec

7D

20.0%

1Y

25.4%

A207940

₩814,000.00

Samsung BiologicsLtd

7D

-1.7%

1Y

4.0%

A145020

₩182,400.00

Hugel

7D

6.7%

1Y

37.2%

A008930

₩41,800.00

Hanmi Science

7D

-4.6%

1Y

27.8%

A028300

₩78,700.00

HLB

7D

14.7%

1Y

146.3%

A000100

₩67,000.00

Yuhan

7D

7.0%

1Y

31.5%

A128940

₩332,000.00

Hanmi Pharm

7D

-1.0%

1Y

29.7%

A196170

₩131,200.00

ALTEOGEN

7D

44.7%

1Y

243.9%

A326030

₩92,600.00

SK Biopharmaceuticals

7D

8.4%

1Y

41.4%

A182400

₩1,957.00

NKMAX

7D

-21.7%

1Y

-68.7%

A086900

₩184,000.00

Medy-Tox

7D

-3.1%

1Y

-13.6%

A235980

₩13,190.00

MedPacto

7D

31.8%

1Y

-33.3%

A328130

₩67,400.00

Lunit

7D

9.2%

1Y

199.9%

A085660

₩17,140.00

ChabiotechLtd

7D

-4.6%

1Y

20.1%